Skip to main content

Table 1 Characteristics of patients with primary membranous nephropathy

From: Alteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy

Case

Age

Sex

sCre

M-alb/cre (mg/g cre)

Stage

HT

Duration of disease prior to biopsy (months)

Hematuria

Previous Treatment

MN1

65

M

0.65

2931

II

+

24

+/−

ARB

CCB

Statin

MN2

78

M

0.95

1120

III

+

12

2+

ARB

CCB

MN3

72

M

0.86

8188

I

-

8

3+

-

MN4

65

M

1.25

4306

II

-

4

2+

-

MN5

46

M

0.93

4136

I

+

2

3+

ARB

MN6

79

M

0.90

3168

I

+

6

2+

ARB

CCB

Statin

ConA1

33

M

0.60

12

-

-

-

2+

-

ConA2

27

F

0.60

7.6

-

-

-

1+

-

ConA3

46

M

0.98

6.2

-

-

-

2+

-

  1. sCre serum creatinine (mg/dL), stage the stage of disease according to the Ehrenreich–Churg classification, ARB angiotensin II type 1 receptor blocker, CCB calcium channel blocker, ConA1-3 three controls in a series of consecutive patients, which were subjected to a renal biopsy with finding of microhematuria without proteinuria and no pathological findings of glomerulonephropathy